· Intro
· Max concentration
· Rate of removal
· MLAC
Local anaesthetic |
· Antagonist at axonal voltage-gated Na+ channel (VDNaC) |
Drug path |
· Axoplasm -> interstitium -> plasma · Only unionised drug diffuses readily |
Determinants of rate of offset |
1. Maximum concentration in axoplasm 2. Rate of removal from axoplasm 3. Minimum local analgesic concentration (MLAC) |
· ↑Concentration of solution
· ↑Volume injected
Fick’s law |
|
↓C1 |
· ↑VDNaC affinity -> ↓dwell time (e.g. bupiv) · ↑Tissue protein binding (e.g. bupiv) **most important factor |
↑C2 |
Drug: · Intrinsic vasoconstriction (e.g. ropiv constrict cf. lignocaine dilate) · Added adrenaline · Slow metabolism -> slow removal (e.g. amidase cf. plasma cholinesterase) Patient: · Low intrinsic blood flow (decreasing order: tracheal / intercostal / caudal / paracervical / epidural / plexus / peripheral nerve / subcut) * · Tissue hypoperfusion (↓ if heart failure, shock; ↑if pregnancy, neonate) · Slow metabolism (e.g. neonate) |
↓Area |
|
↑Thickness |
· ↑Size of nerve (e.g. sciatic cf. median) · ↑Connective tissue (e.g. sciatic cf. median) · ↓Distance from centre of bundle (i.e. distal cf. proximal target) |
↓Diffusion coeff (minor) |
· ↓Lipid solubility (e.g. lignocaine 150x cf. bupiv 1000x procaine) · ↑Molecular weight · ↓% unionised (e.g. bupiv 15% cf. lignocaine 25%); or ↓tissue pH |
Nerve sensitivity |
· Myelination (3 consecutive nodes of Ranvier ≈ 1cm) · ↑Frequency of action potential · ↓Nerve diameter -> ↓ratio surface area : axon unit volume
Order of decreasing sensitivity: B > C > Aδ > Aγ > Aβ > Aα (sensory 2x motor) |
Patient |
· ↑Tissue pH · Pregnancy |
Drug |
·
↑Potency (ropiv 8x ligno 2x) |
Additives |
· Opioid · α2 agonist |
Feedback welcome at ketaminenightmares@gmail.com